
A combination of medications and a particular light therapy has been found to be effective in treating certain types of head and neck cancers.
During a study, researchers focused on the use photodynamic therapy (PDT) in tropical climates.
Advertisement
The treatment uses a drug called a photosensitizer, or photosensitizing agent, and a particular type of light.
The study involved 24 males and 22 females, with an average age of 66 years. A total of 82 different lesions were treated, mostly in the oral cavity and vocal chords.
The findings revealed that organ preservation and cancer cure can be achieved in patients with recurrent cancer that is superficially spread in the head and neck, but not deeply infiltrated.
However, the authors cautioned that patients need extensive instruction on how to take the medications and follow-up counseling.
PDT is usually performed as an outpatient procedure, may be repeated, and may be used with other therapies, such as surgery, radiation, or chemotherapy, giving patients a variety of treatment options.
The study was presented at 2009 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting and OTO EXPO in San Diego.
Source: ANI
LIN
Advertisement
The findings revealed that organ preservation and cancer cure can be achieved in patients with recurrent cancer that is superficially spread in the head and neck, but not deeply infiltrated.
However, the authors cautioned that patients need extensive instruction on how to take the medications and follow-up counseling.
PDT is usually performed as an outpatient procedure, may be repeated, and may be used with other therapies, such as surgery, radiation, or chemotherapy, giving patients a variety of treatment options.
The study was presented at 2009 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting and OTO EXPO in San Diego.
Source: ANI
LIN
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.